While this latter link provides only correlative evidence, we note that the frequent concurrent expression of CD58 and CMTM6 in human tumors provides support for the notion that the mechanistic effects here modeled in vitro and in a humanized mouse model may also be at play in human cancer. This evidence concerns the gene CD58 and cancer.